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ABSTRACT
International Journal of Exercise Science 15(2): 645-654, 2022. The placebo effect of caffeine has been poorly
investigated in endurance exercise. Therefore, the aim of this study was to analyze the placebo effect of caffeine on
4 km running performance in amateur runners. Twenty-two healthy and recreational male runners (25.5 ± 8.4 yrs;
75.0 ± 7.1 kg; 173.7 ± 6.3 cm) underwent a deceptive experimental design consisting of three different sessions: a)
control (CON) in which participants did not ingest any substance; b) placebo (PLA) in which participants ingested
a capsule filled with maltodextrin but they were informed that they would receive caffeine; c) caffeine (CAF) in
which participants were informed that they would receive caffeine and actually received caffeine. After 60 min for
substances absorption, participants performed a 4-km test and they completed the distance as fast as possible. The
time employed to cover the distance was lower in PLA (17.4 ± 1.5 min) and CAF (17.4 ± 1.4 min) than CON sessions
(18.6 ± 2.8 min; P<0.05). There were no differences in the 4-km times between PLA and CAF (P>0.05) and no
differences were reported between treatments for RPE (P>0.05). In conclusion, there was a placebo effect of caffeine
on a 4-km maximal running trial which entailed that believing to have ingested caffeine improved performance to
a similar extent than actually receiving caffeine. Therefore, the expectancy induced by caffeine may be one of the
mechanisms behinds the ergogenic effect of this stimulant on endurance exercise.
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INTRODUCTION
Caffeine has been widely used to increase performance in both aerobic and anaerobic activities
(3,12). The action of caffeine to increase performance can be mainly explained by central
mechanisms (i.e., increase in cortical and spinal excitability, and enhanced release of
neurotransmitters that produce augmented muscle fiber conduction velocity and motor unit
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recruitment (14). Specifically, caffeine has the capacity to blunt the fatiguing effects of adenosine
on the central nervous system through its antagonism on adenosine receptors A1, A2A and A2B
of various tissues (8). Therefore, when caffeine is ingested acutely in a dose of 3-to-9 mg/kg of
body mass, this stimulant delays fatigue during exercise (8), enhances performance (11) and
decreases the rate of perceived exertion in both resistance and dynamic aerobic exercises (2).
Additionally, caffeine can produce peripheral changes, such as the increase in intracellular
calcium concentration (10), the attenuation of potassium ion concentration (16) and enhanced
muscle oxygenation in active muscles (20) that may contribute to its ergogenicity.
The ergogenic effect of caffeine appears to occur regardless of dose and time of ingestion (24).
However, there are recent data suggesting the possibility of a placebo effect associated to
caffeine on exercise performance (1,4,23). The placebo effect of caffeine can be defined as a
psychobiological response, mainly displayed as an increase in physical performance or feelings
of performance, that arises from the belief that caffeine has been ingested when in fact, the
participant has received a placebo (13). This effect can be explained by the fact that response
expectancy (if the participant believes he/she ingested caffeine and he/she is aware that caffeine
is a potent ergogenic substance that may increase performance) promotes the endogenous
release of opioids and non-opioids, facilitating the activation of pain and non-pain control
systems (7). Interestingly, this effect is associated to caffeine because it is a substance with a wellrecognized ergogenic effect and, due to its wide consumption in the diet, most individuals have
experienced the effect of acute caffeine intake. In this context, the psychophysiological variables
induced by the believe of caffeine ingestion (motivation, expectancy, and conditioning) can
interact significantly with physiological variables such as muscle activation of motor units or
reduced pain and effort acting positively -or negatively- on exercise performance (5).
The relationship between the placebo effect of caffeine and enhanced physical performance has
been documented in the literature (4,13), although this is not always the case (25). To this regard,
most studies on the placebo effect of caffeine have been performed using randomized, doubleblind, placebo-controlled, crossover designs but the deceptive protocols contain substantial
differences. Overall, the deceptive protocols contain a trial where participants are informed of
receiving an ergogenic dose of caffeine when in fact, they received a placebo. Exercise
performance in this trial is normally compared to a trial where participants actually received
caffeine, although more complex experiments have arisen in the last years (1,25). However, the
ergogenic effect of caffeine is not only explained by its placebo effect as most of experiments
with caffeine use a placebo trial to eliminate this effect (21) and there are evidence indicating
that verified differences between the psychological and physiological effect of caffeine. For
example, Polito et al. (18) verified the effect of two doses of caffeine on the performance of
resistance exercise, while the sample believed that one of the doses was placebo. Even though
the sample believed they ingested a placebo, performance was higher than in the control session
(without substances).
Studies with these deceptive designs are still relatively scarce in the literature, especially the
ones that investigate the placebo effect of caffeine on endurance exercise. It may be worthwhile
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analyzing the potential psychological effect of believing to have ingested caffeine on physical
performance, through deceptive protocols, to ascertain if this is a mechanism that contributes to
the ergogenic effect of actual caffeine intake. Thus, the aim of this study was to investigate the
existence of a placebo effect of caffeine on 4 km running performance in amateur runners.
METHODS
Participants
An a priori power analysis using statistical software (G*power V 3.1.9.4) was completed to
determine an adequate sample size. Thus, 22 healthy male runners volunteered to participate in
this study, depicted in Table 1. As inclusion criteria, individuals were required to be aged
between 18-40 years of age, have a minimum of six months of endurance running training, have
no injuries in the lower limbs in the previous six months, no respiratory or cardiovascular
diseases, low-to-moderate caffeine consumption (< 2-3 cups of coffee) and no allergy to caffeine.
Participants who were undergoing restrictive diet control or were using stimulants and
nutritional supplements were excluded from the study. Participants were encouraged to
maintain a normal diet and exercise habits throughout the duration of the study, and they were
asked to abstain from caffeine intake for the duration of the study, and to refrain from vigorous
exercise for at least 48 hours prior to testing. Participants signed an informed written consent
prior to participating in the investigation where they were fully informed of the experimental
procedures and risks. Informed consent was obtained from each participant before data
collection and all experimental procedures were approved by the Research Ethics Committee
Involving Humans of the State University of Londrina. This research was carried out in
accordance with the ethical standards of the International Journal of Exercise Science (17).
Table 1. General characteristics of the sample (n=22).
Variables
Age (years)
Weight (kg)
Height (cm)
Body fat (%)
Sleep (hours/day)
Usual running training per day (km)
Daily coffee consumption (ml)

Mean
25.5±8.4
75.0±7.1
173.7±6.3
19.9±4.4
8.2±0.5
5.5±2.6
346.5±198.2

Protocol
Following a deceptive, randomized, double-blind, placebo-controlled, and crossover
experimental design, data collection was performed on three non-consecutive trials with a
minimum interval of 72 h. Participants performed a maximum test consisting of the completion
of a distance of 4 km running while participants were encouraged to complete this distance in
the lowest time possible. Participants performed this test in three different conditions: a) control
(CON) in which participants did not ingest any substance; b) placebo (PLA) in which
participants ingested a capsule filled with maltodextrin but they were informed that they would
receive 4 mg/kg of caffeine; c) caffeine (CAF) in which participants were informed that they
would really receive 4 mg/kg of caffeine. In PLA and CAF, the capsules were identical, and they
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were ingested 60 min before the onset of the 4-km test. To avoid possible interferences of the
time of the day on the outcomes of the investigation, the trials were performed in the afternoon
(2 pm) and in a laboratory with well-controlled ambient conditions (~22ºC and ~60% of relative
humidity).
Once participants fulfilled all the inclusion criteria and signed the informed consent, they were
encouraged to avoid any type of caffeine-containing foods and beverages until the completion
of the experiment (e.g., coffee, tea, chocolate, etc.). One week before the onset of the experiment,
participants arrived to the laboratory to familiarize with the experimental procedures and they
were weighed unclothed at this day to calculate caffeine dose for the CAF trial. In this session,
participants were informed about the findings of research related to acute effects of caffeine
intake on endurance exercise performance through informal conversations that included
information about the ergogenic effect of caffeine, dosage and most common side effects. Then,
the participants were instructed to meet the following conditions 24-h before each experimental
trial: (i) to avoid vigorous exercise, (ii) to adopt a similar diet and drink intake, (iii) to refrain
from the consumption of alcohol, and other stimulants (iv) to sleep at least 8 h in the night before
the tests. In the experimental trials, participants arrived at the laboratory in a fed state (~3 hours
after their last meal). Upon arrival, participants ingested the capsule in the PLA and CAF trials
and rested for 60 min. In the CON trial, participants ingested for the same duration but there
was not capsule ingestion. Afterwards, participants performed a 10-min standardized warmup and then they performed the 4-km running test.
The running test was performed on an electrical treadmill set with a slope of 0%. The speed of
the treadmill was progressively increased until it reached the speed desired for the participants
and then the test started. Individuals were encouraged to run the distance as fast as possible in
the shortest possible time and standardized verbal motivation was given. Participants were able
to control the speed during the whole trial through an accessible dashboard, they received
information about the distance left to complete the trial but there was no information of the
actual speed and the time employed since the beginning of the trial. During the test, times and
rating of perceived exertion (RPE) were recorded every 1 km using the 6-to-20-point Borg Scale
(6). This information was collected by an investigator who was blinded to the treatment assigned
to each participant. After the end of the test, participants performed a 3-min cool-down period
at 5 km/h and they were discharged.
Statistical Analysis
The normality of the data was verified by the Shapiro-Wilk test and the homogeneity of
variances by the Levene test. Given the assumptions of normal distribution, two-way ANOVA
was applied to verify the effect of CON, PLA, and CAF on the times to complete each 1-km
interval during the test and on the total 4-km running time. The same procedure was used to
verify the results in the RPE. Tukey's post-hoc tests were used in the case of a significant F test.
In all cases, a p-value less than 0.05 was considered as the level of statistical significance.
Additionally, to determine the magnitude of the findings, Cohen’s d effect sizes (ES) were
calculated for the differences between PLA and CAF, following the classification: small
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(0.20<ES<0.50), medium (0.50≤ES<0.80) or large (ES≥0.80). The data were analyzed using the
software Statistica 10.0 (Statsoft, Tulsa, OK, USA). Data are presented as means ± standard
deviations.
RESULTS
Table 2 shows the total running time and the running pace for the 1st, 2nd, 3rd, and 4th km of each
trial. The intra-session analysis demonstrated that the pace per kilometer tended to increase in
CON (P=0.03), to decrease CAF (P=0.02), and remain constant in the PLA (P=0.75). In CON, the
pace of the 1st km was slower than the 2nd km (P=0.03); the pace of the 2nd km was faster than
the 3rd km (P=0.01) and the 4th km (P=0.02); and the pace of the 3rd km was faster than the 4th km
(P=0.04). In CAF, the pace of the 1st km was slower than the 2nd (P=0.02), 3rd (P=0.02) and 4th km
(P=0.02). The inter-session comparisons showed that the pace of the 1st km of PLA was quicker
than that of the other two trials (P=0.02). In the 2nd km there were no differences among the three
trials. In the 3rd km, only CAF was quicker than CON (P=0.01); and in the final kilometer, both
PLA and CAF presented faster paces than the CON session (P=0.02; P<0.01, respectively). PLA
and CAF conditions were similar in relation to the total time but participants employed a lower
total time compared to CON in these two trials (P=0.03; P=0.01, respectively).
The ES for all inter-session and intra-session comparisons at running pace was considered small
(ES<0.50). For the total running time, the ES was considered medium both in the PLA vs CON
(ES=0.53) and CAF vs CON (ES=0.54) comparison.
Table 2. Total time and pace per kilometer (in minutes) in the different sessions.
Pace per kilometer
Total time
1stkm
2ndkm
3rdkm
4thkm
4 km
CON
4.7±1.0
4.4±0.61
4.6±0.62
4.9±1.32,3
18.6±2.8
PLA
4.3±0.4#
4.3±0.5
4.4±0.6
4.4±0.6†
17.4±1.5*
CAF
4.6±0.5
4.4±0.41
4.2±0.51‡
4.2±0.51†
17.4±1.4*
st
Numbers represent intra-group comparisons: 1 = Different from the 1 km of the same session; 2 = Different from
the 2nd km of the same session; 3 = Different from the 3 rd km of the same session. Symbols represent inter-group
comparison: * Different from the total time of the control session; † Different from the 4 th km of the control session;
‡ Different from the 3rd km of the control session; # Different from the 1st km of the control session and from the 1st
km of the caffeine session. All differences were set at p < 0.05.

Table 3 describes RPE values obtained every 1 km intervals in the three situations under
investigation. Although the RPE increased throughout the test in all trials there were no
significant differences among the treatments. In all cases, the ES was small (ES<0.40).
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Table 3. Rating of perceived exertion every 1 km.
Rating of perceived exertion
st
nd
1 km
2 km
3rdkm
CON

12.9±1.7

13.9±1.21

14.7±1.41

4thkm
15.1±1.91

PLA
12.8±1.4
14.1±1.21
15.3±1.41
15.4±1.81
1
1
CAF
12.1±1.6
13.8±1.2
14.9±1.4
15.8±1.51,2
st
Numbers represent intra-group comparisons. 1 = Different from the 1 km; 2 = Different from the 2nd km. All
differences were set at p < 0.05.

DISCUSSION
The aim of this study was to investigate the existence of a placebo effect of caffeine on 4 km
running performance in amateur runners to demonstrate the utility o the expectation of
ingesting caffeine as an ergogenic tool to enhance performance. The main results of the study
were: a) there was a placebo effect of caffeine, since the real intake of caffeine and the expected
ingestion of caffeine increased running performance to the similar extent when compared to the
control session; b) there were no differences in RPE between sessions indicating that participants
performed the trials with the same feelings of exertion. These outcomes suggest that believing
to have ingested caffeine improved running performance to a similar extent than actually
receiving caffeine. Therefore, the expectancy induced by caffeine may be one of the mechanisms
behinds the ergogenic effect of this stimulant on endurance exercise.
The construct used in the present study including a deceptive design in which participants were
informed that caffeine would be offered on two days to determine the consistency of the
ergogenic effect of caffeine. However, on one day, the capsule ingested contained a placebo and
in the other day, the capsule contained 4 mg/kg of caffeine. This procedure was applied to avoid
bias of motivation, as this design prevented that if the subject believed that caffeine was ingested
on the first day he would not be less motivated for the second day. In this context, the perception
of the ingested substance can be an important factor related to enhanced performance,
particularly for caffeine’s erogenicity. For example, Saunders et al. (12) used caffeine and
placebo, in comparison to a control situation, to assess performance in trained cyclists during a
30 min cycling trial. Afterwards, the cyclists were were asked about which supplement they
believed they had ingested ("caffeine", "placebo", "don't know") and they were allocated to
subgroups for analysis according to their identifications. Interestigly, the results showed that
the actual ingestion of caffeine enhanced cycling performance but in those cyclists who correctly
identified the trial with caffeine, the ergogenic effect of this stimulant was slightly higher. In
addition, there was a tendency for a better over the control situation when they ingested placebo
but they believed that it was caffeine. On the other hand, Beedie et al. (4) informed cyclist that
they would receive one dose of placebo and two doses of caffeine, whereas, in fact, the authors
provided three placebo substances. The results showed that performance improved when
athletes believed they had ingested caffeine and worsened when they believed they had
ingested placebo. In another experiment, in which individuals received placebo while they were
told they had received caffeine, similar results were observed in 1000-m running performance
when compared to a situation where they received caffeine (14). The current results study to this
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topic as the placebo effect of caffeine was found on a 4-km running test. All these results suggest
that both, the actual ingestion of caffeine and the believe of ingesting caffeine are independent
parts of the ergogenic effect of this substance. To this regard, the presence of one factor (actual
ingestion or the believe of ingestion) has the potential of increasing performance but the
combination of these two likely offers an additive effect.
In the current study, participants believed they had ingested caffeine at two trials, which may
have contributed to the improve performance when they in fact ingested the placebo. This can
be explained by two hypotheses. Firstly, some subjects may experience side effects in relation to
caffeine intake, and some of these side effects may occur even after taking the placebo (if the
subject believes they have ingested caffeine). Secondly, another factor that could have
contributed to the placebo effect of caffeine is the “feeling” of performance during the trial (such
as perception of speed or pace). Thus, an expectation of response can be generated, in which the
participant feels more motivated to impose more effort in relation to the session, even when they
had ingested an inert substance. This is only applicable to substances who are ergogenic and to
individuals who are aware to the ergogenic effect of this substance as the deceptive protocol and
the placebo effect will not be produced in those individuals who are not aware of the benefit of
caffeine. To this regard, participants in the current investigation were selected due to their lowto-moderate consumption of caffeine, to assure that they have experience and knowledge about
the effect of caffeine during exercise while they were informally lectured about the findings of
research related to acute effects of caffeine intake on endurance exercise.
One physiological justification for this finding of this study that the expectancy of caffeine intake
may promote the endogenous release of opioids and non-opioids, facilitating the activation of
pain and non-pain control systems (7). This was verified in a study in which a false placebo was
administered in a resistance exercise protocol, when in fact received a dose of caffeine (18). In
the present study, participants were blinded in relation to speed and time during each trial and
thus, they did not receive any objective information to anticipate their performance. However,
as the sample had running experience, it is possible that their perception of the pace influenced
the result of the ingestion of the placebo, at least in relation to the control situation. Thus,
psychophysiological variables, such as motivation, expectation, and conditioning can interact
with physiological variables, such as muscle mass and activation of motor units, acting
positively on performance (5). These explanations seem to be centered on the OPTIMAL theory,
that is, Optimizing Performance Through Intrinsic Motivation and Attention for Learning (26).
According to this model, the increase in expectations, support for autonomy, and external focus
influence performance and motor learning. Thus, the supposed relationship of these reward
factors provides an increased dopaminergic response, triggering better performance and
building structural and functional brain connectivity.
In addition to the total time of the 4-km run, there was carried out an analysis of the pace for
each kilometer covered. Curiously, in the control session, the pace of the run was progressively
reduced while the reduction in running performance was not seen in the other two treatments.
This suggests that the second half of the run was decisive for the results and both, the ingestion
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of caffeine and the believe of receiving it were equally effective to reduce fatigue in the second
half of the 4-km run.
Regarding the interaction of caffeine with RPE, the results of the meta-analysis by Doherty and
Smith (9) suggest that caffeine intake decreases RPE by 5.6%. However, our results did not
identify differences in RPE between sessions. One of the possible explanations for this
divergence is that the subjects were instructed to run the distance in the shortest possible time,
thus characterizing maximum effort in all sessions. Therefore, in spite of the reduced time in the
PLA and CAF sessions, the high level of physical demand prevented any change in the RPE, as
participants exerted their maximum effort in all trials. Similarly, Astorino et al. (2) did not
identify differences in RPE in a 10-km time trial when comparing caffeine intake and placebo.
In addition, RPE during exercise is multifactorial and, ultimately, may not be related to physical
performance (22).
Although the results were positive for the adopted experimental design, we understand that the
study has some limitations. For example, the diet in the day prior to the trials was not
standardized. However, the analysis of the dietary recall did not identify any differences in the
energy intake nor in macronutrients proportions among trials. In addition, the duration of the
4-km run was likely not enough to produce influence of glycogen depletion on the results of the
investigation. Second, the sample of individuals included in this investigation had a low-tomoderate intake of caffeine. Further investigations are necessary to indicate if the placebo effect
of caffeine is affected by the habituation of caffeine as in those athletes highly habituated to
caffeine, the use of this type of deceptive experiments may not be successful. In addition,
tolerance to the ergogenic effect of caffeine may affect the placebo effect of caffeine due to both
reduction of the positive and negative effects of this substance (15,19). Finally, the experimental
design could have included a broader approach, covering a real placebo condition and a caffeine
ingestion condition with a placebo expectation. Thus, in the face of a scenario where new
investigations can be conducted using different ranges of intensity and volume in the run, we
suggest experiments taking into account individual expectations and perceptions about caffeine
intake.
In conclusion, there was a placebo effect of caffeine on a 4-km maximal running trial which
entailed that believing to have ingested 4 mg/kg of caffeine improved performance to a similar
extent than actually receiving this dose of caffeine. Therefore, the expectancy induced by
caffeine may be one of the mechanisms behinds the ergogenic effect of this stimulant on
endurance exercise. The use of a placebo can be used to increase 4-km running performance in
trained men who are aware of the ergogenic benefits of this substance and under a deceptive
protocol, representing an alternative to the use of caffeine.
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